Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application

Br J Dermatol. 2009 Apr;160(4):887-9. doi: 10.1111/j.1365-2133.2009.09042.x. Epub 2009 Feb 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / drug therapy*
  • Male
  • Middle Aged
  • NF-kappa B / drug effects
  • Remission Induction
  • Skin Neoplasms / drug therapy*
  • Thalidomide / therapeutic use*

Substances

  • Antineoplastic Agents
  • NF-kappa B
  • Thalidomide